TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q3)Aug 31, 2024 | (FY)May 31, 2024 | (Q9)Feb 29, 2024 | (Q6)Nov 30, 2023 | (Q3)Aug 31, 2023 | (FY)May 31, 2023 | (Q9)Feb 28, 2023 | (Q6)Nov 30, 2022 | (Q3)Aug 31, 2022 | (FY)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 38.18%325.22M | ---- | ---- | ---- | 119.29%235.36M | ---- | ---- | ---- | -630.51%-1.22B |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | 749.32%60.32M | ---- | ---- | ---- | -86.20%7.1M | ---- | ---- | ---- | 3,662.13%51.47M |
Impairment and provisions: | ---- | 233.92%29.4M | ---- | ---- | ---- | -98.44%8.8M | ---- | ---- | ---- | 418.88%564.93M |
-Other impairments and provisions | ---- | 233.92%29.4M | ---- | ---- | ---- | -98.44%8.8M | ---- | ---- | ---- | 606.00%564.93M |
Revaluation surplus: | ---- | -2,312.21%-19.03M | ---- | ---- | ---- | -94.24%860K | ---- | ---- | ---- | 290.51%14.93M |
-Other fair value changes | ---- | -2,312.21%-19.03M | ---- | ---- | ---- | -94.24%860K | ---- | ---- | ---- | 290.51%14.93M |
Asset sale loss (gain): | ---- | -108.54%-185K | ---- | ---- | ---- | 109.85%2.17M | ---- | ---- | ---- | -509.00%-22M |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | --2.17M | ---- | ---- | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---185K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---22M |
Depreciation and amortization: | ---- | -12.94%106.82M | ---- | ---- | ---- | -36.89%122.7M | ---- | ---- | ---- | -15.63%194.43M |
-Depreciation | ---- | -14.00%100.65M | ---- | ---- | ---- | -39.14%117.04M | ---- | ---- | ---- | -14.79%192.29M |
-Amortization of intangible assets | ---- | 8.95%6.17M | ---- | ---- | ---- | 165.06%5.67M | ---- | ---- | ---- | -55.33%2.14M |
Special items | ---- | 80.33%101.23M | ---- | ---- | ---- | -80.65%56.13M | ---- | ---- | ---- | 1,264.90%290.03M |
Operating profit before the change of operating capital | ---- | 39.40%603.77M | ---- | ---- | ---- | 442.42%433.13M | ---- | ---- | ---- | -121.04%-126.49M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -88.20%-41.21M | ---- | ---- | ---- | -1,303.24%-21.9M | ---- | ---- | ---- | -51.49%1.82M |
Accounts receivable (increase)decrease | ---- | -68.27%3.29M | ---- | ---- | ---- | 133.43%10.37M | ---- | ---- | ---- | -486.82%-31.03M |
Accounts payable increase (decrease) | ---- | 55.23%198.04M | ---- | ---- | ---- | 138.99%127.58M | ---- | ---- | ---- | -345.51%-327.24M |
prepayments (increase)decrease | ---- | -512.21%-108.63M | ---- | ---- | ---- | -142.10%-17.74M | ---- | ---- | ---- | 376.74%42.14M |
Cash from business operations | ---- | 23.30%655.26M | ---- | ---- | ---- | 220.56%531.44M | ---- | ---- | ---- | -161.42%-440.8M |
Other taxs | ---- | -47.85%21.72M | ---- | ---- | ---- | 1,811.56%41.65M | ---- | ---- | ---- | -93.50%2.18M |
Special items of business | -45.44%183.21M | 12.00%445.66M | 35.75%745.81M | 77.30%636.37M | 81.26%335.79M | 147.27%397.91M | 141.95%549.4M | 133.39%358.92M | 141.49%185.25M | -322.20%-841.83M |
Net cash from operations | -45.44%183.21M | 15.62%1.12B | 35.75%745.81M | 77.30%636.37M | 81.26%335.79M | 175.83%971.01M | 141.95%549.4M | 133.39%358.92M | 141.49%185.25M | -213.31%-1.28B |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | ---- | 41.85%-1.39M | ---- | ---- | ---- | 93.12%-2.39M | ---- | ---- | ---- | -301.51%-34.72M |
Decrease in deposits (increase) | ---- | 12.61%-179.53M | ---- | ---- | ---- | -288.25%-205.43M | ---- | ---- | ---- | 94.17%-52.91M |
Sale of fixed assets | ---- | -68.03%423K | ---- | ---- | ---- | -75.44%1.32M | ---- | ---- | ---- | -88.13%5.39M |
Purchase of fixed assets | ---- | -74.35%-249.39M | ---- | ---- | ---- | 5.10%-143.05M | ---- | ---- | ---- | 64.88%-150.74M |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | -57.68%2.11M | ---- | ---- | ---- | --4.99M |
Purchase of intangible assets | ---- | ---34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | --886K | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | -15.98%2.01B | ---- | ---- | ---- | 16.77%2.4B | ---- | ---- | ---- | -40.95%2.05B |
Cash on investment | ---- | -29.50%-2.7B | ---- | ---- | ---- | -235.28%-2.09B | ---- | ---- | ---- | 85.72%-622.92M |
Other items in the investment business | -41.79%-295.16M | ---- | -183.26%-289.91M | -20.72%-301.2M | -6.59%-208.17M | ---- | -107.27%-102.35M | -138.19%-249.5M | -208.91%-195.3M | -167.01%-33.91M |
Net cash from investment operations | -41.79%-295.16M | -2,984.45%-1.15B | -183.26%-289.91M | -20.72%-301.2M | -6.59%-208.17M | -103.20%-37.41M | -107.27%-102.35M | -138.19%-249.5M | -208.91%-195.3M | 153.66%1.17B |
Net cash before financing | -187.72%-111.95M | -103.35%-31.28M | 1.98%455.9M | 206.33%335.18M | 1,369.98%127.62M | 934.16%933.6M | 360.12%447.05M | 125.96%109.42M | 96.24%-10.05M | 89.32%-111.92M |
Cash flow from financing activities | ||||||||||
Issuing shares | ---- | -69.48%3.93M | ---- | ---- | ---- | 7,258.86%12.88M | ---- | ---- | ---- | -99.99%175K |
Issuance expenses and redemption of securities expenses | ---- | 73.72%-63.18M | ---- | ---- | ---- | -8.29%-240.39M | ---- | ---- | ---- | ---222M |
Other items of the financing business | -1,081.54%-153.49M | -422.84%-101.19M | 69.94%-51.21M | 84.95%-17.72M | 35.02%-12.99M | -114.18%-19.35M | 5.36%-170.35M | -3.97%-117.75M | -1,749.49%-19.99M | 94.27%-9.04M |
Net cash from financing operations | -1,081.54%-153.49M | 35.01%-160.44M | 69.94%-51.21M | 84.95%-17.72M | 35.02%-12.99M | -6.93%-246.87M | 5.36%-170.35M | -3.97%-117.75M | -1,749.49%-19.99M | -113.96%-230.86M |
Effect of rate | 193.70%27.49M | 67.55%-24.61M | 47.70%-21.04M | 96.62%-2.14M | -7.17%-29.34M | 20.03%-75.83M | -5.70%-40.23M | -34.04%-63.37M | -88.62%-27.37M | -189.31%-94.82M |
Net Cash | -331.56%-265.44M | -127.92%-191.72M | 46.25%404.69M | 3,909.66%317.46M | 481.56%114.63M | 300.34%686.73M | 434.08%276.7M | 98.44%-8.33M | 88.80%-30.04M | -156.51%-342.78M |
Begining period cash | -11.98%1.59B | 51.14%1.81B | 51.14%1.81B | 51.14%1.81B | 51.14%1.81B | -26.81%1.19B | -26.81%1.19B | -26.81%1.19B | -26.81%1.19B | 77.52%1.63B |
Cash at the end | -28.54%1.35B | -11.98%1.59B | 52.98%2.19B | 88.88%2.12B | 66.27%1.89B | 51.14%1.81B | -5.31%1.43B | 6.92%1.12B | -15.73%1.14B | -26.81%1.19B |
Cash balance analysis | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.